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www.cl in icalnutr i t ionexper imental .comThe most cited papers in the ﬁrst six issues of Clinical
Nutrition ExperimentalRecently, the European Society for Clinical Nutrition and Metabolism (ESPEN) decided to keep its
main journal, Clinical Journal, for human studies, and to create a new journal to publish animal studies
and basic science related to clinical nutrition. During the ﬁrst year of the newly launched Clinical
Nutritional Experimental journal, numerousmanuscripts have been submitted. The tremendouswork of
Rocco Barrazoni, Joel Faintuch, Jianchu Ju, NEP Deutz, Jurgen Bauer and Oren Tirosh, the associate
editors, together with the most valuable efforts of the reviewers have created the content framework
for this new journal.
In the ﬁrst six issues of Clinical Nutrition Experimental, several interesting articles were of note. The
special issue on the role of microbiota in different diseases has been read and cited in many publi-
cations. Laure Bindels and Jean Paul Thissen are the authors of the most-cited article “Nutrition in
cancer patients with cachexia: a role for the gut microbiota” [1], which shows evidence regarding the
crosstalk between the gut microbiota and the intestine, and its use as potential therapeutic manage-
ment in cancer and its related cachexia. Another paper titled “Perinatal nutrition: how to take care of
the gut microbiota?” [2] analyzed the interesting inﬂuence of maternal microbiome and nutrition on
infant gut microbiota formation. The article “Food for thought: the role of nutrition in the micro-
biotaegutebrain axis” [3] from the same issue summarizes the strong evidence showing an inﬂuence
of microbiota on behavior and brain function. Dietary intervention can modulate psychiatric symp-
toms. Microbiota can also contribute to the pathogenesis and/or onset of celiac disease [4].
Weight-loss interventions are changing gut microbiota, and many questions are raised in the Dao
article [5] “Can we predict the response to a speciﬁc intervention and could some preintervention
modiﬁcations to the gut microbiota optimize the weight loss and the metabolic modiﬁcations?” The
Weizmann Institute team [6] is developing a personalized diet based on normal or aberrant response to
a diet in patients with type 2 diabetes mellitus. This is based on ﬁndings showing mechanisms by
which the microbiome is contributing to diabetes mellitus. Therefore, its manipulation can lead to
therapeutic interventions for hyperglycemia and its prevention.
This journal is giving an opportunity for preliminary ﬁndings to be published. In rats fed with
revestrol, grape fruit or red wine, Souza Rocha et al. showed that revestrol and grape juice were able to
increase muscle tissue FNDC5 gene expression [7]. A high-fat diet, isolated or associated with
polyphenol-enriched beverages, could decrease this same expression in adipose tissue. Dupertuis et al.
[8] described a rapid and low-cost method of experimental radio/chemotherapy in tumor xenografted
chicken chorioallantoic membrane (CAM). Tumor spheroid grafting, positron emission, and CT imaging
could be helpful, and provide solid alternatives to other time-consuming methods. In a project to
explore the onset of metabolic syndrome and insulin-associated hepatic complications, unacylated
ghrelin (UnAG) has the potential to lower oxidative stress in different cell types, the impact of thishttp://dx.doi.org/10.1016/j.yclnex.2016.07.001
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the up-regulation of UnAG did not alter any of these parameters [9]. A new device to prevent
gastroesophageal reﬂux has been described by Avitzur et al. [10], and the ﬁndings of preliminary ex-
periments show that the device is safe, and increasingly promising in preventing reﬂux and, possibly,
aspiration and ventilator-associated pneumonia.
Clinical Nutrition Experimental is promising to become a journal for those who have nutrition-
related basic science and technologies to publish. Preliminary ﬁndings and well-established data are
welcome. This research in the ﬁeld of nutrition is the corner stone in the development of clinical
nutrition.
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